Clinical and neuropsychological predictors of posttraumatic stress disorder by Suliman, Sharain et al.
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Sharain Suliman, PhD, Dan J. Stein, MD, PhD, and Soraya Seedat, MD, PhD
Abstract: Although acute responses to traumatic stress generally
resolve within a few weeks, some individuals experience severe and
persistent problems, such as posttraumatic stress disorder (PTSD).
While studies have identified a variety of predictors of PTSD, not all
data are consistent. This longitudinal study examined the predictive
power of neurocognitive deficits with regard to PTSD severity.
One hundred thirty one road traffic collision (RTC) survivors
were included within 2 weeks of the RTC and followed up 3 and
6 months later to determine severity of PTSD.
Impairment on tests of information processing, executive func-
tioning, verbal learning, and motor speed predicted PTSD severity
when neuropsychological, clinical, and sociodemographic factors
were all taken into account. Clinical variables (initial symptoms,
psychiatric diagnoses, disability, trait anxiety, perceived stress,
negative cognitions, and sleep) were associated with 3 and 6-month
PTSD severity, but only trait anxiety was predictive of PTSD
severity. Ethnicity and education were also found to be predictive.
These findings suggest implementation of a holistic approach to
screening for PTSD and support a need for interventions that target
neurocognitive, clinical, and social variables. Early targeted profiling
of this group of trauma survivors can inform early clinical
interventions and policy.
(Medicine 93(22):e113)
Abbreviations: ASDS = Acute Stress Disorder Scale, CAPS =
Clinician-Administered PTSD Scale, CD-RISC = Connor–David-
son Resilience Scale, DSM = Diagnostic and Statistical Manual,
DS = digit span, DSy = digit symbol/coding, GPT = Grooved
Pegboard Test, MINI = MINI International Neuropsychiatric
Interview, PSS = Perceived Stress Scale, PSQI = Pittsburg Sleep
Quality Index, PTCI = Posttraumatic Cognitions Inventory, PTSD
= Posttraumatic stress disorder, RAVLT = Rey Auditory Verbal
Learning Test, RTC = road traffic collision, SDS = Sheehan
Disability Scale, STAI-T = Spielberger State-Trait Anxiety
Inventory-Trait Version, SS = symbol search, ToL = Tower of
London, TMT = Trail Making Test, VR = visual reproduction.
INTRODUCTION
There is accumulating evidence that early interventionstrategies are useful in preventing posttraumatic stress
disorder (PTSD), with some studies suggesting that there is
a window of brain plasticity during the acute trauma
response that presents an opportunity to affect the final
outcome.1 Two meta-analyses and several reviews of PTSD
risk factors have identified key factors influencing PTSD
vulnerability. These include pre-trauma factors such as
family psychiatric history, prior psychological adjustment,
previous trauma exposure, characteristics of the traumatic
experience (namely, trauma severity), peritraumatic emo-
tional reactions (namely, dissociation), and post-trauma
social support.2–5 However, Brewin et al2 cautioned against
attempts to build a general vulnerability model for all cases
of PTSD based in their findings, as they found that there
were substantial sectors of the population for whom gender,
age at trauma, and race could not be shown to be risk
factors at all, indicating that other identifiers are needed.
There have been relatively few prospective studies of
PTSD that have measured risk factors before the traumatic
event,2 although there have been some that have measured
risk factors post-trauma but prior to the onset of PTSD. Due,
in part, to methodological limitations of extant research, the
role of neuropsychological factors and structural and func-
tional changes of the brain in the evolution of PTSD are also
less well understood.6 Neuropsychological dysfunction in
both acute and chronic PTSD includes disturbances of
learning, memory, attention, concentration, and executive
functions.7–10 Whether these deficits are precursors to or a
consequence of PTSD, or risk factors present prior to or
early on in the trauma response, is unclear.
Only 3 published studies have prospectively assessed
for cognitive deficits. These have implicated verbal memory,
sustained attention, verbal learning, visuospatial memory,
and reaction-time proficiency deficits, and trends toward
poorer cumulative learning and verbal fluency in the predic-
tion of PTSD severity.11–13 Educational achievement pre-
trauma and lower intelligence quotient (IQ) (albeit within the
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normal range) have also been reported to be associated with
PTSD symptoms.14,15 Studies in twin pairs have further
highlighted that poorer performance on certain neurocogni-
tive tests may indicate a vulnerability factor for developing
symptoms of PTSD rather than solely representing an
outcome of PTSD symptoms.16,17 Taken together, these
studies suggest that neurocognitive capacities may serve as
premorbid risk or protective factors in PTSD and may relate
to processes that determine the resolution versus the mainte-
nance of early posttraumatic reactions.
The aims of this study were to extend existing
knowledge of early neuropsychological predictors of PTSD.
The primary aim was to examine the predictive power of
neurocognitive deficits with regard to PTSD severity, while
taking potentially confounding clinical, road traffic collision
(RTC)-related, and sociodemographic variables into account.
The secondary aim was to determine if neurocognitive
performance and psychiatric symptoms, such as those
associated with anxiety, disability, and acute stress disorder
(ASD) at 2 weeks post-trauma, were associated with severity
of PTSD symptoms. We hypothesized that worse early
neurocognitive performance and clinical symptoms would
significantly predict short-term (3 months) and long-term
(6 months) outcome.
METHODS
Design
This was a prospective study of risk factors that could
potentially predict the development of PTSD severity, based
on the Clinician-Administered PTSD Scale (CAPS18) score,
in a sample of RTC survivors.
Procedures
Ethics approval for the study was obtained from the
Health Research Ethics Committee, Stellenbosch University,
and the hospital departments where recruitment took place
(in the Cape Town region of South Africa). The participants
were assessed at baseline (approximately 10 days post-RTC),
using clinical and neurocognitive measures and followed up
3 and 6 months later to assess for PTSD severity. Assess-
ments were conducted by researchers trained in all measures
and written informed consent was obtained from all partic-
ipants prior to study inclusion.
Sample
One hundred thirty-eight RTC survivors, who were
involved in RTCs as drivers, passengers, or pedestrians, were
recruited. The participants were eligible for the study if they
were willing and able to provide written informed consent,
between the ages of 18 and 65 years, able to read and write
in English at 5th grade level. In order to avoid interference
with participation in the study and potential confounding
variables, participants were excluded if they had a current or
past history of psychosis; any significant recent or previous
head injury (defined as loss of consciousness for >24 hours
and/or posttraumatic amnesia and/or traumatic brain injury);
use of any psychotropic medication at the initial assessment;
serious physical injury or threat to life at inclusion (as
determined by the Abbreviated Injury Scale19 and chart
records, ie, no serious threat to life), or where injury
sequelae would interfere with study participation according
to the judgment of the investigator; and/or cognitive
impairment. Because of missing data, the final sample
consisted of 131 participants.
Measures
A demographic questionnaire was used to collect informa-
tion on age, gender, education, employment, household
income, whether the participant was the breadwinner, marital
status, living arrangements, ethnicity (whether the participant
was of white, black, Indian, or mixed race/colored ancestry),
and past and current medical and psychiatric history.
Clinical Measures
The clinical measures are as follows.
1. The CAPS18 was our main outcome measure. It provides
current and lifetime PTSD diagnostic information in
addition to frequency and intensity scores of individual
PTSD symptoms.
2. The MINI International Neuropsychiatric Interview
(MINI20) is a clinician-administered, structured diagnostic
interview for major psychiatric disorders based on
Diagnostic and Statistical Manual (DSM)-IV diagnostic
criteria, and was used to determine past and current
psychiatric disorders in the sample.
3. The Acute Stress Disorder Scale (ASDS21) is a self-report
inventory, based on DSM-IV criteria for ASD.
4. The Spielberger State-Trait Anxiety Inventory-Trait Ver-
sion (STAI-T22) is a self-rated scale that measures current
anxiety symptoms. The trait version measures a more
general and longstanding anxiety, as opposed to tempo-
rary state anxiety.
5. The Perceived Stress Scale (PSS23) is a measure of the
degree to which situations in one’s life are appraised as
stressful. Items are designed to tap how unpredictable,
uncontrollable, and overloaded respondents find their lives.
6. The Connor–Davidson Resilience Scale (CD-RISC24) is a
self-report measure that assesses stress-coping ability.
7. The Sheehan Disability Scale (SDS25) asks respondents
to rate the amount of disability caused by a specific
disorder in the domains of work, home management,
social life, and close relationships. Domain scores are
added up to provide a total score.
8. The Posttraumatic Cognitions Inventory (PTCI26) assesses
trauma-related cognitions in 3 domains, negative cogni-
tions about self, negative cognitions about the world, and
self-blame, which are added up to provide a total score.
9. The Pittsburg Sleep Quality Index (PSQI27) indicates
sleep quality in 7 domains that are then added to yield 1
global score.
Neuropsychological Measures
The neuropsychological measures are as follows.
1. The Wechsler Abbreviated Scale of Intelligence28 is a short
and reliable measure of intelligence that can be used in
clinical, psychoeducational, and research settings. The 2
subtest form, consisting of a vocabulary and matrix reasoning
test, was used to assess cognitive ability of the participants.
2. Trail Making Test (TMT29) is a 2-part test for memory,
speed of attention, sequencing, mental flexibility, visual
search, and motor and executive function. Part A was
used as a measure of information processing and Part B
of executive functioning.
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3. The Wechsler Adult Intelligence Scale-III30 is a measure
of general intellectual function in older adolescents and
adults, in which 3 subtests were used:
– Digit span (DS) is a 2-part test that assesses auditory
attention, concentration, memory for digits (digits
forward) and working memory (digits backward).
– Digit symbol/coding (DSy) is a test of psychomotor
performance, visual-motor coordination, sustained at-
tention, and motor and mental speed.
– Symbol Search (SS) assesses for attention, visual
perception, and response speed.
4. The Stroop Test31 is a measure of selective attention and
cognitive flexibility.
5. The Rey Auditory Verbal Learning Test (RAVLT32)
measures new learning and verbal memory (immediate
recall, short and long-term retention of information).
6. The Wechsler Memory Scale-R33 visual reproduction (VR)
subtest is a task of immediate and delayed visual memory.
7. The Tower of London (ToL)34 tests for the ability to plan
ahead/executive functioning. The total move score was
used as a measure of executive planning.
8. The Wechsler Intelligence Scale for Children-Mazes35 test
yields data about the highest levels of mental functioning
involving planning and foresight, and is sensitive to
executive disorders. Although designed for children, they
give a rough estimate of adult performance.
9. Grooved Pegboard Test (GPT36) is a test of manual
dexterity, complex coordination, and fine motor skill.
Data Analyses
Statistica 12 (StatSoft Inc, Tulsa, OK, 2013) was used
to analyze the data, with no replacement of missing data. All
data available at a particular time point were used for the
analyses. We conducted reliability analyses of the clinical
measures, all of which were within acceptable limits, with
Cronbach alpha values ranging from 0.62 to 0.95. Severity
of PTSD at 3 and 6 months were the primary outcome
measures. Univariate analyses (correlations, analysis of vari-
ance) were first conducted for all neuropsychological and
clinical predictors and any potential confounders (ie, demo-
graphic, social, and RTC-related factors). In order to identify
the variables that were most predictive of 3 and 6-month
PTSD severity, all clinical and neuropsychological variables,
and any confounding variable that emerged as significant or
showed a trend toward significance (P< 0.10), were entered
into a best subsets regression analysis. This method compares
all possible models using a specified set of predictors and
displays the best-fitting models possible allowing for a
choice of the optimal model.37 Tolerance statistics deter-
mined that there were no problems of multicollinearity.
RESULTS
Demographic Characteristics
One hundred thirty-one participants were included in the
study. Of these, 104 (79.5%) returned for the 3-month follow-
up and 101 (77.1%) for the 6-month follow-up. Baseline
characteristics did not differ between the full sample and the
participants who returned for their 3 and 6-month follow-up
visits (P> 0.05).
The majority of the sample was male (56.5%), of
colored ethnicity (44.3%), married (29.8%), or living with a
partner (35.1%), family member(s) (51.8%), or a significant
other (26.6%). The average age of the sample was 33.05
(10.54) years. Participants had a mean of 10.02 (2.75)
years of education; most were employed (77.9%) and
breadwinners (61.8%), but only 39.7% had household
incomes of more than  $10,000 per annum.
Injury Characteristics
The majority of participants were passengers in a car
(28.2%) or pedestrians (28.2%). RTCs took place, on
average, 9.98 (4.78) days prior to the initial assessment.
Based on the Abbreviated Injury Scale, approximately half
the sample (52.7%) had minor injuries (a score of 1) while
the remainder had moderate injuries (a score of 2).
Medical and Psychiatric History
Previous medical history (ie, heart problems, tuberculo-
sis) was reported in 41.2%, and 76.7% had been prescribed
medication to treat either a medical condition or injury
resulting from the RTC; 17.6% reported previous psychiatric
history (ie, depression or anxiety) and 13.7% had been
prescribed psychiatric medication in the past. At baseline,
current major depressive disorder (18.5%) and alcohol abuse
(16.9%) were the most common diagnoses. The participants
had an average of 3.78 (2.41) traumas prior to the accident,
with the most common lifetime traumas being assault with a
weapon (47.3%) and prior involvement in an RTC (45.0%).
Neuropsychological Predictors
Descriptive statistics and the relationship of PTSD
severity to individual neuropsychological measures are
presented in Table 1.
DSy and ToL scores were significantly associated with
PTSD severity 3 months after the trauma, and the TMT (A)
and (B), DSy, SS, RAVLT learning score, ToL, and the GPT
were significantly associated with PTSD severity at 6 months
post-trauma. DSy, SS, and RAVLT learning were negatively
correlated so that those with more severe PTSD performed
worse in these tasks, and ToL, GPT, and TMT (A) and (B)
were positively correlated indicating that those with more
severe symptoms took longer or made more moves in
completing these tasks.
Confounding variables (those that previous research has
indicated are associated with neurocognitive outcomes) that
were significantly associated with any of the neuropsychologi-
cal test scores (P< 0.05), or that showed a trend toward
significance (P< 0.10), were included in the regression
analyses. As income and education were significantly corre-
lated (r¼ 0.52, P< 0.001), we excluded income as a con-
founder. Variables that were included were age, education,
ethnicity, medication use at the time of the accident, and IQ.
Clinical Predictors
Baseline clinical characteristics of the sample and their
relationships to 3 and 6-month PTSD severity are displayed
in Table 2. There were no significant differences present
between participants who did and did not return for follow-
up visits (P> 0.05). The mean CAPS score at baseline was
33.35 21.08, and 30 participants (22.9%) met criteria for
PTSD using a cutoff of 50, excluding the time criterion. The
mean CAPS score at the 3-month visit was 29.57 19.49
with 20 participants (19.6%) meeting criteria for a diagnosis
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of PTSD. This number dropped to 22.11 17.22, with 12
participants (12.2%) meeting criteria at the 6-month visit.
Three and 6 months after the trauma, baseline disability
(SDS), trait anxiety (STAI-T), perceived stress (PSS), negative
cognitions (PTCI), sleep disturbances (PSQI), ASD (ASDS),
and the presence of any MINI disorder (most commonly
depression, dysthymia, generalized anxiety disorder, and risk
for suicide) were positively associated with PTSD severity
indicating that those with higher scores on these scales were
likely to have worse PTSD symptoms. Resilience (CD-RISC)
was negatively associated with PTSD severity 3 but not 6
months post-trauma, suggesting that lower resilience was
associated with worse symptoms at 3 months.
Potential confounding variables included those that have
previously been found to be associated with PTSD and are
listed in Table 3. Those that were significantly associated
TABLE 1. Neuropsychological Predictor Variables and Their Relationship to PTSD Severity at 3 and 6 mo
3 mo 6 mo
Variable (Range) Mean SD r Significance r Significance
TMT-A (14–159) 40.37 16.91 0.05 0.634 0.22 0.038*
TMT-B (41–238) 93.13 39.64 0.06 0.607 0.22 0.042*
DS:DF (4–16) 8.98 2.64 0.03 0.782 0.02 0.887
DS:DB (0–13) 5.22 2.30 0.72 0.496 0.17 0.107
DSy (0–86) 51.30 16.01 0.21 0.044* 0.28 0.014*
SS (0–42) 25.20 6.88 0.11 0.281 0.25 0.036*
RAVLT I (1–10) 5.37 1.25 0.07 0.514 0.04 0.701
RAVLT VI/V (42–133) 83.48 17.98 0.17 0.109 0.07 0.541
RAVLT VII/V (50–140) 79.03 20.28 0.03 0.808 0.04 0.730
RAVLT learning (1–10) 5.64 1.98 0.01 0.918 0.25 0.019*
Stroop (2 to 68) 37.45 10.18 0.13 0.226 0.14 0.186
ToL (4–83) 36.74 16.92 0.28 0.008** 0.23 0.038*
Mazes (95–994) 298.10 136.28 0.06 0.595 0.04 0.754
VR I (8–41) 32.02 6.53 0.08 0.437 0.18 0.089
VR II (0–40) 28.17 9.31 0.02 0.824 0.20 0.066
GPT (193–288) 159.62 38.39 0.20 0.073 0.36 0.001**
DB¼ digits backward, DF¼ digits forward, DSy¼ digit symbol, GPT¼Grooved PegBoard Test, Mazes¼Maze task, RAVLT¼Rey
Auditory Verbal Learning Test, SD¼ standard deviation, SS¼ symbol search, Stroop¼ Stroop Test, TMT¼Trail Making Test, ToL¼Tower of
London, VR¼ visual reproduction.
*P 0.05; **P 0.001.
TABLE 2. Clinical Characteristics of Sample and Their Relationship to PTSD Severity at 3 and 6 mo Follow-Ups
3 mo 6 mo
Baseline Variable % (N)/Mean SD r/F Significance r/F Significance
CAPS score (range: 2–95) 33.35 21.08 r ¼ 0.45 0.001** r ¼ 0.41 0.001**
ASDS (range: 20–89) 51.4 17.4 r ¼ 0.23 0.027* r ¼ 0.22 0.042*
Any MINI diagnoses
Yes 54.2% (71)
No 44.3% (58) F(1,76) = 5.40 0.023* F(1,78) = 6.30 0.014*
SDS (range: 1–30) 12.85 9.70 r ¼ 0.40 0.001** r ¼ 0.33 0.003**
STAI-T (range: 20–71) 47.36 9.37 r ¼ 0.50 0.001** r ¼ 0.42 0.001**
PSS (range: 4–34) 32.30 13.42 r ¼ 0.23 0.047* r ¼ 0.25 0.023*
CD-RISC (range: 8–100) 71.65 16.58 r ¼ 0.25 0.030* r ¼ 0.06 0.607
PTCI (range: 33–180) 95.04 34.17 r ¼ 0.38 0.001** r ¼ 0.44 0.001**
PSQI (range: 1–25) 9.81 5.53 r ¼ 0.25 0.028* r ¼ 0.24 0.030*
WASI (range: 5–103) 63.21 18.88 r ¼ 0.17 0.107 r ¼ 0.22 0.041*
ASDS¼Acute Stress Disorder Scale, CAPS¼Clinician-Administered PTSD Scale, CD-RISC¼Connor–Davidson Resiliency Scale, MINI¼
MINI International Neuropsychiatric Interview, PSQI¼ Pittsburg Sleep Quality Index, PSS¼Perceived Stress Scale, PTCI¼Posttraumatic
Cognitions Inventory, SD¼ standard deviation, SDS¼Sheehan Disability Scale, STAI-T¼Spielberger State-Trait Anxiety Inventory-Trait
Version, WASI¼Wechsler Abbreviated Scale of Intelligence.
“F” stands for difference; “r” stands for correlation.
*P 0.05; **P 0.001.
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with PTSD severity (P< 0.05) or approached significance
(P< 0.10) were included in the regression analyses. Again,
as income and education were significantly related, income
was excluded from the analyses. Notably, variables such as
age and gender, which have been well established in
previous studies as pre-trauma risk factors across trauma
type, were not significantly associated with PTSD severity.
Variables that were controlled for, therefore, included educa-
tion and ethnicity at 3 and 6 months.
Clinical and Neuropsychological Predictors of
PTSD
All clinical and neuropsychological predictors and potential
confounders of PTSD were included in best subsets regression
models to determine those that were most consistently predictive.
The 3-month model was significant and explained
approximately 50% of the variance (R2¼ 0.53, adjusted
R2¼ 0.46, F(7,48)¼ 7.73, P< 0.001). Six predictors were
retained in the model—education, ethnicity, STAI, TMT (A),
DSy, and SS. All were significant and were most consistently
predictive in the 20 best models too (Table 4).
The 6-month model retained 7 predictors—education,
ethnicity, STAI, TMT (A), Maze Test, RAVLT-learning
score, and VR-delayed recall, which were all significant.
The overall model was also significant and explained
approximately 40% of the variance (R2¼ 0.48, adjusted
R2¼ 0.39, F(7,41)¼ 5.41, P< 0.001). The retained predictors
also appeared to be the most consistently predictive variables
in the 20 best models (Table 5).
DISCUSSION
This sample of RTC survivors had moderately severe
PTSD symptomatology; 22.9% met criteria for PTSD at
baseline (although the duration criterion, >1 month, was not
met) and rates of PTSD at 3 and 6 months were 19.6% and
12.2%, respectively. The objective of this study was to extend
existing knowledge of early predictors of PTSD severity. In
order to do this, we analyzed neuropsychological and clinical
variables and their associated sociodemographic factors
separately before combining them. We expected baseline
sociodemographic, injury characteristics, neuropsychological,
and clinical variables to influence vulnerability to PTSD.
TABLE 3. Variables Controlled for at 3 and 6 mo and Their Relationship to PTSD Severity
3 mo 6 mo
Variable r/F Significance r/F Significance
Gender F(1,76) ¼ 0.00 0.980 F(1,78) ¼ 0.00 0.985
Age r ¼ 0.08 0.502 r ¼ 0.08 0.490
Education r ¼ 0.24 0.034* r ¼ 0.27 0.015*
Ethnicity F(2,75) ¼ 2.71 0.073 F(2,77) ¼ 2.68 0.075
Income r ¼ 0.32 0.005** r ¼ 0.32 0.004**
Medication use F(1,76) ¼ 1.57 0.214 F(1,78) ¼ 1.89 0.173
Days since RTC r¼ 0.17 0.127 r ¼ 0.06 0.620
Marital status F(3,73) ¼ 1.64 0.187 F(3,75) ¼ 0.27 0.848
Religiously active F(1,76) ¼ 0.01 0.931 F(1,78) ¼ 0.01 0.919
Psychological history F(1,76) ¼ 1.57 0.214 F(1,78) ¼ 1.89 0.173
Injured as a driver, passenger or pedestrian F(3,74) ¼ 0.84 0.476 F(3,76) ¼ 1.38 0.257
Severity of injury F(1,76) ¼ 0.63 0.429 F(1,78) ¼ 0.03 0.857
Number of previous traumatic events r¼ 0.09 0.455 r ¼ 0.07 0.568
“F” stands for difference; “r” stands for correlation.
RTC¼ road traffic collision.
*P 0.05; **P 0.001.
TABLE 4. Best Subsets Regression Results for 3-mo Visit
Unstandardized Coefficients Standardized Coefficients
Model Beta Std. Error Beta T Significance No. of Times in Best 20 Models
(Constant) 8.54 19.08 0.45 0.656
Education 1.96 0.90 0.24 2.17 0.035* 18
Ethnicity (colored) 9.89 4.29 0.25 2.30 0.026* 14
STAI-T 0.91 0.28 0.41 3.22 0.002** 20
TMT-A 0.55 0.21 0.33 2.65 0.012* 20
DSy 0.47 0.19 0.35 2.48 0.017* 19
SS 1.19 0.45 0.37 2.66 0.011* 18
DSy¼ digit symbol, SS¼ symbol search, STAI-T¼Spielberger State-Trait Inventory-Trait Version, TMT-A¼Trail-Making Test-A.
*P 0.05; **P 0.001.
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Although numerous studies3,5 have reported a relation-
ship between PTSD severity and various patient character-
istics, we mostly did not find this to be the case. We,
however, did find that lower levels of education and
ethnicity were associated with follow-up PTSD severity.
Education also appears to be one of the most consistent
predictors of PTSD severity. It may be that lower educational
levels are associated with dysfunctional cognitive and coping
styles. Ethnicity too appears to be useful in predicting PTSD
in both the short and longer terms, with “colored” ethnicity
seeming to be protective. Although this finding is in contrast
to a systematic review of factors that predict PTSD after
RTCs, which found that ethnicity had no utility in predicting
PTSD,5 there are some studies that have found ethnicity to
relate to the trauma response.38
Cognitive changes resulting from trauma exposure or
preexisting maladaptive cognitive styles may play a critical
role in the development of PTSD.39,40 Furthermore, memo-
ries of the traumatic event and interpretations of one’s PTSD
symptoms or the consequences of the traumatic event may
become associated with automatically activated negative
evaluations.41,42 Although all our clinical variables were
found to be associated with PTSD severity 3 and 6 months
post-RTC (with the exception of resilience that was only
associated with PTSD severity at 3 months post-trauma), trait
anxiety was the only one found to predict PTSD severity. In
line with our previous findings of an association between
trait anxiety and ASD severity,43 this suggests that individua-
ls with a predisposition to anxiety problems are prone to
developing clinically significant stress responses in relation
to life stressors.44,45 Thus, it seems that a close examination
of temperamental variables, such as the tendency to respond
with elevations in anxiety to perceived stressful situations,
may lead to better predictions of risk and vulnerability
associated with PTSD. In this study, it was the best and most
consistent predictor of 3 and 6-month PTSD severity.
Stress-related neurobiological activity is thought to alter
the function, and potentially even the structure, of several brain
regions mediating the stress response.46 Neurobehavioral alter-
ations, in turn, may promote survival by directing focus to
potential sources of danger and away from irrelevant aspects
of the environment.47 Since the ability to simultaneously
engage in multiple focused cognitive activities is not unlimited,
the diversion of cognitive resources to processing potential
threat occurs at the expense of other cognitive activities.48
Thus, although this response can result in heightened behavior-
al reactivity, it can also result in attenuated attention, learning,
and memory for nonthreat-relevant stimuli and events.49,50
Accordingly, PTSD is associated with significant
impairments in cognitive functioning.51 In the current study,
we found that executive function and information-processing
deficits were associated with PTSD severity at both time
points (3 months: DSy and ToL tasks; 6 months: DSy, SS,
TMT (A and B), and ToL tasks). Poorer verbal learning and
motor speed were also associated with 6-month PTSD
severity. Furthermore, tasks of information processing (TMT-
A, DSy, and SS), executive functioning (Maze Test), verbal
learning (RAVLT), and delayed visual memory (VR) were
all significantly predictive of later PTSD severity.
PTSD has been associated with poor speed, accuracy,
and depth of information processing.52–54 Cognitive slowing
may be attributable to reduced attentional resources,55 which
could be a consequence of brain resources being directed
toward coping with psychological distress, unpleasant inter-
nal experiences,56 or potential threats in the environment (ie,
hypervigilance) rather than the task needing attention.
Verbal and visual memory deficits, as well as immediate
and delayed memory, have previously been found to be
predictive of PTSD.11–13,17 This suggests that more limited
verbal abilities, specifically with regard to acquisition and
encoding,54,57,58 and difficulty retaining newly learned visual
information—whether inherited or a response to life stresses—
may increase the risk of PTSD in individuals exposed to trauma
while enhanced verbal abilities may act as a protective factor.59
Sustained attention12 and working memory13 have been
found to predict PTSD. We did not find that tests of working
memory, that is, DS, were predictive of PTSD severity, but
we did find more complex tasks of planning and foresight,
that is, the Maze Test to be predictive of longer-term PTSD.
This suggests that impairment is more likely to be detected
on tests of more complex executive function abilities,60 and
points toward impairments in executive function that relate
to the severity of PTSD symptoms, and may serve as a risk
factor for the development of the disorder,7 for example, by
reducing the individual’s capacity to suppress intrusions.61
Abnormalities in executive functioning might reflect frontal–
subcortical impairment,53 which possibly also contributes to
hallmark symptoms of PTSD, such as heightened arousal and
TABLE 5. Best Subsets Regression Results for 6-mo Visit
Unstandardized Coefficients Standardized Coefficients
Model Beta Std. Error Beta T Significance No. of Times in Best 20 Models
(Constant) 62.54 20.64 3.03 0.004**
Education 1.96 0.89 0.27 2.21 0.033* 10
Ethnicity (colored) 12.98 4.48 0.35 2.90 0.006** 17
STAI-T 1.13 0.24 0.56 4.65 0.000** 20
TMT-A 0.43 0.21 0.30 2.09 0.043* 13
Mazes 0.05 0.02 0.30 2.34 0.024* 14
RAVLT learning 2.56 1.15 0.25 2.22 0.032* 14
VR-II 0.85 0.31 0.41 2.79 0.008** 20
Mazes¼Maze Test, STAI-T¼Spielberger State-Trait Inventory-Trait Version, TMT-A¼Trail-Making Test-A, RAVLT¼Rey Auditory
Verbal Learning Test, VR¼ visual reproduction.
*P 0.05; **P 0.001.
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re-experiencing symptoms and the reliance on avoidant
coping strategies.7
The primary aims were to identify whether neuro-
cognitive factors are useful in the temporal prediction of
PTSD severity and examine the predictive power afforded by
their interaction with clinical, sociodemographic, and RTC-
related variables. We hypothesized that these variables would
significantly predict both shorter (3-month PTSD severity)
and longer-term (6-month PTSD severity) outcomes. The 3
and 6-month models were both significant, predicting
approximately 50% and 40% of the variance, respectively.
We also expected participants with more severe PTSD at
3 and 6 months to significantly demonstrate more cognitive
impairments than participants with fewer symptoms. Although
not true of all neurocognitive tests, tests of information
processing, executive functioning, verbal learning, and motor
speed were related to PTSD severity on univariate analyses, as
well as when neuropsychological, clinical, and sociodemo-
graphic factors were all taken into account (with the exception
of motor speed).
Finally, we expected that participants with more severe
PTSD at 3 and 6 months would have more psychiatric
symptoms, such as those associated with anxiety, psychiat-
ric disability, or ASD at 2 weeks post-trauma. All clinical
variables assessed (ASD, PTSD symptoms, other psychiatric
diagnoses, disability, trait anxiety, perceived stress, negative
cognitions, and sleep) were associated with 3 and 6-month
PTSD severity on univariate analyses, with the exception of
resilience, which was only associated with 3-month PTSD
severity. Of these, trait anxiety was the only clinical
variable found to be predictive of PTSD severity and was
consistently the best predictor.
These findings are limited by a number of factors.
These data were collected prior to the development of PTSD,
but subsequent to a traumatic event, future studies would
benefit from the inclusion of participants prior to trauma.
The sample consisted of individuals who had experienced a
RTC. Although this avoids potential trauma-related con-
founders, the generalizability of findings is limited. The
possibility that medical and surgical factors (ie, physical
injury and medication use) may have influenced clinical and
cognitive responses cannot be excluded. However, as we
controlled for potential confounders where bivariate relation-
ships were observed, these are unlikely to account for the
relationships we did find. Furthermore, a larger sample size
would have resulted in increased power to detect predictors.
These limitations notwithstanding, the present data offer
preliminary evidence for the role of acute neuropsychologi-
cal, clinical symptomatology and sociodemographic variables
in the temporal prediction of PTSD, in a South African
sample of RTC survivors. The strengths of the study include
the longitudinal nature, reliable measures used in assessment
of PTSD, ASD, and other psychiatric disorders, a wide range
of possible predictors that were included, and potential
confounders that were controlled for.
These findings will hopefully lead to a better understand-
ing of the development and early maintenance of PTSD and
serve as a starting point for the development of a screening
measure to identify individuals at increased risk of PTSD. This
would allow for targeted interventions to treat early negative
symptoms and prevent the development of longer-term nega-
tive psychiatric sequelae. Furthermore, understanding the acute
trauma response may aid in the development of more focused
interventions that can reverse early PTSD or prevent the
development of the disorder. Recent research indicates that
attention modification programs, for example, may be benefi-
cial in anxiety disorders,62,63 suggesting that research related to
attention and working memory function may not only increase
our understanding of PTSD but also lead to more effective
treatments.7 Implications of these findings therefore suggest
the inclusion of neuropsychological measures in the screening
of PTSD symptoms, and support a need for treatments that
address neurocognitive variables, as well as cognitive and
emotional adaptation strategies in the maintenance of PTSD.
In conclusion, this study shows that a combination of
neuropsychological, clinical, and sociodemographic charac-
teristics have the best predictive value for PTSD severity in
this sample, supporting the need for interventions that target
these variables. Given that PTSD can have profound effects
on patients and society, early, targeted profiling of this
group of trauma survivors can inform early clinical
interventions and policy.
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